Dyadic International, Inc. (DYAI)
0.3401
-0.03
(-7.25%)
USD |
NASDAQ |
Nov 05, 16:00
Dyadic International Net Income (Quarterly) : -2.124M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.124M |
| March 31, 2026 | -1.955M |
| December 31, 2025 | -1.567M |
| September 30, 2025 | -1.976M |
| June 30, 2025 | -1.794M |
| March 31, 2025 | -2.028M |
| December 31, 2024 | -1.551M |
| September 30, 2024 | -0.2035M |
| June 30, 2024 | -2.045M |
| March 31, 2024 | -2.010M |
| December 31, 2023 | -2.072M |
| September 30, 2023 | -1.614M |
| June 30, 2023 | -2.153M |
| March 31, 2023 | -0.9564M |
| December 31, 2022 | -2.146M |
| September 30, 2022 | -1.809M |
| June 30, 2022 | -3.288M |
| March 31, 2022 | -2.492M |
| December 31, 2021 | -4.214M |
| September 30, 2021 | -1.715M |
| June 30, 2021 | -3.846M |
| March 31, 2021 | -3.295M |
| December 31, 2020 | -1.960M |
| September 30, 2020 | -2.500M |
| June 30, 2020 | -2.651M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.214M |
| December 31, 2019 | -1.738M |
| September 30, 2019 | -1.698M |
| June 30, 2019 | -2.696M |
| March 31, 2019 | -2.175M |
| December 31, 2018 | -0.5123M |
| September 30, 2018 | -1.540M |
| June 30, 2018 | -1.597M |
| March 31, 2018 | -2.043M |
| December 31, 2017 | -1.368M |
| September 30, 2017 | -1.515M |
| June 30, 2017 | -1.350M |
| March 31, 2017 | 2.096M |
| December 31, 2016 | -2.062M |
| September 30, 2016 | -1.165M |
| June 30, 2016 | 0.5569M |
| March 31, 2016 | -0.9381M |
| December 31, 2015 | -0.6196M |
| September 30, 2015 | 1.328M |
| June 30, 2015 | -0.4232M |
| March 31, 2015 | -0.3807M |
| December 31, 2014 | -1.685M |
| September 30, 2014 | -1.048M |
| June 30, 2014 | -1.679M |
| March 31, 2014 | -1.569M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.9611M |
| Total Expenses (Quarterly) | 3.085M |
| EPS Diluted (Quarterly) | -0.0583 |
| Enterprise Value | 12.77M |
| Gross Profit Margin (Quarterly) | -2.39% |
| Profit Margin (Quarterly) | -221.0% |
| Earnings Yield | -62.51% |
| Normalized Earnings Yield | -62.51 |